Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
February 20, 2019

Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma

Merck has secured approval from the US Food and Drug Administration (FDA) for its Keytruda (pembrolizumab) as the adjuvant treatment for patients with melanoma with involvement of lymph node(s) following complete resection.

Continue
Image: Merck’s anti-PD-1 therapy Keytruda. Photo: courtesy of Merck Sharp & Dohme Corp.
February 20, 2019

Roche secures FDA priority review for entrectinib and polatuzumab vedotin

Image: Roche's entrectinib and polatuzumab vedotin get FDA priority review. Photo: courtesy of F. Hoffmann-La Roche Ltd.
February 19, 2019

Additional data analysis offers greater insight into phase 2 findings of Bionomics’ PTSD drug

Image: Bionomics’ BNC21 has showed significant effect in phase 2 post traumatic stress disorder trial. Photo: courtesy of everydayplus / FreeDigitalPhotos.net.

Contracts

February 14, 2019

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Image: World's largest pharmaceutical company is set to implement ValGenesis100% paperless Validation Lifecycle Management System. Photo: courtesy of jk1991 / FreeDigitalPhotos.net.

Amprologix wins DHSC backing for new antibiotic

Lupin awards MALT1’s licensing rights to AbbVie

Ixico secures expanded contract from major biopharmaceutical firm

Deals

Deals February 14, 2019

Clinigen to acquire US rights to Novartis cancer drug Proleukin

Pharmaceutical Business Review

Neuraxpharm acquires CNS specialty pharma company Farmax

Hitachi Chemical to acquire apceth Biopharma

Circassia to buy US, China marketing rights to AIT’s AirNOvent

Popular

  1. Innovation Pharmaceuticals receives new patent for compounds for use in treatment of oral mucositis
  2. Pfizer secures approval from European Commission for Avastin biosimilar
  3. Innovent, Chipscreen Biosciences to assess combination therapy in colorectal cancer patients
  4. Knight Therapeutics signs Latin American funding deal with Moksha8
  5. Decipher announces research collaboration with Dendreon to identify genomic drivers of patient response to Sipuleucel-T

PRESS RELEASES

Master Your Supply Chain with End-to-End Visibility Webinar
Master Your Supply Chain with End-to-End Visibility Webinar
Porton Biopharma Appoints New Chair
Porton Biopharma Appoints New Chair
Webinar: How Analysis by Spectroscopy Optimises Agriculture of Grasslands
Webinar: How Analysis by Spectroscopy Optimises Agriculture of Grasslands
Understanding Current Requirements for Pharmaceutical Validation
Understanding Current Requirements for Pharmaceutical Validation
Grading Separator for Pharmaceutical Powders
Grading Separator for Pharmaceutical Powders

Suppliers

Whitepapers

RAM II – FT-Raman Module
RAM II – FT-Raman Module
HYPERION Series of FTIR Microscopes
HYPERION Series of FTIR Microscopes
INVENIO R – Intuitive FTIR R&D Spectrometer
INVENIO R – Intuitive FTIR R&D Spectrometer